Evidence map›Paper›PMID 33091867›Full record

ArticleJournal of colloid and interface science2021

Adsorption of non-ionic surfactant and monoclonal antibody on siliconized surface studied by neutron reflectometry.

Zhenhuan Zhang, Ann Marie Woys, Kunlun Hong, Christoph Grapentin, Tarik A Khan, Isidro E Zarraga, Norman J Wagner, Yun Liu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of colloid and interface science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Zhenhuan ZhangCenter for Neutron Research, National Institute of Standards and Technology. Gaithersburg, MD 20899, USA; Center for Neutron Science, Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA.
Ann Marie WoysDepartment of Late Stage Pharmaceutical Development, Genentech Inc., San Francisco, CA 94080, USA.
Kunlun HongThe Center for Nanophase Materials Sciences, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.
Christoph GrapentinPharmaceutical Development and Supplies, Pharma Technical Development, F.Hoffmann-La Roche Ltd, Basel, Switzerland.
Tarik A KhanPharmaceutical Development and Supplies, Pharma Technical Development, F.Hoffmann-La Roche Ltd, Basel, Switzerland.
Isidro E ZarragaDepartment of Late Stage Pharmaceutical Development, Genentech Inc., San Francisco, CA 94080, USA.
Norman J WagnerCenter for Neutron Science, Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA. Electronic address: wagnernj@udel.edu.
Yun LiuCenter for Neutron Research, National Institute of Standards and Technology. Gaithersburg, MD 20899, USA; Center for Neutron Science, Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA. Electronic address: yun.liu@nist.gov.
National Institute of Standards and Technology · USPharmaceutical Product Development (United States) · USRoche (Switzerland) · CHOak Ridge National Laboratory · USUniversity of Delaware · US

Funding

Intramural NIST DOC 9999-NIST
6 · The paper itself

Abstract

The adsorption of monoclonal antibodies (mAbs) on hydrophobic surfaces is known to cause protein aggregation and degradation. Therefore, surfactants, such as Poloxamer 188, are widely used in therapeutic formulations to stabilize mAbs and protect mAbs from interacting with liquid-solid interfaces. Here, the adsorption of Poloxamer 188, one mAb and their competitive adsorption on a model hydrophobic siliconized surface is investigated with neutron scattering coupled with contrast variation to determine the molecular structure of adsorbed layers for each case. Small angle neutron scattering measurements of the affinity of Poloxamer 188 to this mAb indicate that there is negligible binding at these solution conditions. Neutron reflectometry measurements of the mAb show irreversible adsorption on the siliconized surface, which cannot be washed off with neat buffer. Poloxamer 188 can be adsorbed on the surface already occupied by mAb, which enables partial removal of some adsorbed mAb by washing with buffer. The adsorption of the surfactant introduces significant conformational changes for mAb molecules that remain on the surface. In contrast, if the siliconized surface is first saturated with the surfactant, no adsorption of mAb is observed. Competitive adsorption of mAb and Poloxamer 188 from solution leads to a surface dominantly occupied with surfactant molecules, whereas only a minor amount of mAb absorbs. These findings clearly indicate that Poloxamer 188 can protect against mAb adsorption as well as modify the adsorbed conformation of previously adsorbed mAb.

Indexed as

Antibodies, MonoclonalSurface-Active AgentsAdsorptionNeutronsSurface PropertiesAntibodies, MonoclonalSurface-Active AgentsMonoclonal antibodyNeutron reflectometryPoloxamer 188Siliconized surfaceSmall angle neutron scatteringSurface adsorption

Identifiers

PMID33091867
PMCPMC11165629
OpenAlexW3092595357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.